Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $705000.0.

  • Praxis Precision Medicines' Amortizatization of Intangibles fell 6483.79% to $705000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 1232.41%. This contributed to the annual value of $5.0 million for FY2024, which is 49856.63% up from last year.
  • Praxis Precision Medicines' Amortizatization of Intangibles amounted to $705000.0 in Q3 2025, which was down 6483.79% from $987000.0 recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Amortizatization of Intangibles registered a high of $2.0 million during Q3 2024, and its lowest value of -$375000.0 during Q1 2022.
  • Moreover, its 4-year median value for Amortizatization of Intangibles was $218000.0 (2023), whereas its average is $517666.7.
  • In the last 5 years, Praxis Precision Medicines' Amortizatization of Intangibles skyrocketed by 84575.47% in 2024 and then tumbled by 6483.79% in 2025.
  • Praxis Precision Medicines' Amortizatization of Intangibles (Quarter) stood at -$196000.0 in 2022, then surged by 211.22% to $218000.0 in 2023, then surged by 537.61% to $1.4 million in 2024, then tumbled by 49.28% to $705000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $705000.0 for Q3 2025, versus $987000.0 for Q2 2025 and $1.2 million for Q1 2025.